771 completed. 771 Phase 2, 144 Phase 1, 118 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 771 | Completed 771 |
| Phase 1 | 144 | Completed 144 |
| Phase 3 | 118 | Completed 118 |
Follow Pneumonia: new trials by email Literature Review of Pneumonia trials Research Report on Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Lumbrokinase DLBS1033 on D-Dimer, Interleukin-6, and Clinical Outcomes in Patients With Pneumonia and Sepsis Placebo Tablet(s), DLBS1033 - Pneumonia, Sepsis | Phase 2 | Completed | Universitas Sebelas Maret | 50 | 2025-08-14 | 2026-10-23 |
| A Study of S-892216 in Participants With COVID-19 S-892216, Placebo - COVID-19 | Phase 2 | Completed | Shionogi | 282 | 2025-06-06 | 2026-09-21 |
| Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19 Ketamine only - Long COVID | Phase 2 | Completed | University of Texas at Austin | 20 | 2025-06-05 | 2026-09-17 |
| Probiotic Use for Recovery Enhancement From Long COVID-19 Probiotic Agent, Placebo - Post-Acute COVID-19 Syndrome | Phase 2 | Completed | Rush University Medical Center | 194 | 2025-05-13 | 2026-08-07 |
| NE3107 in Adults With Neurological Symptoms of Long COVID NE3107, Placebo - Long COVID | Phase 2 | Completed | BioVie Inc. | 203 | 2025-04-29 | 2026-09-22 |
| A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age mRNA-1083 Composition 1 Dose A Lot A, mRNA-1083 Composition 1 Dose A Lot B, mRNA-1083 Composition 1 Dose B - Influenza, SARS-CoV-2 | Phase 2 | Completed | ModernaTX, Inc. | 1320 | 2025-03-07 | 2025-10-20 |
| Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients With Long COVID Education for self-management, Personalised exercise program, Usual Care - Long COVID Syndrome | Phase 2 | Completed | CEU San Pablo University | 57 | 2025-03-01 | 2026-10-08 |
| EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL Colchicine 0.5 MG Oral Tablet - COVID - 19 | Phase 1 / Phase 2 | Completed | Zaeema Kanwal | 66 | 2025-02-24 | 2025-09-04 |
| A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People Investigational Influenza Vaccine, Investigational COVID-19 Vaccine, Investigational Influenza and COVID-19 Combination Vaccine - Influenza, COVID-19 (Coronavirus Disease 2019) | Phase 1 / Phase 2 | Completed | BioNTech SE | 2650 | 2025-02-10 | 2026-01-26 |
| Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults With Post-COVID-19 Condition (PCC) Plitidepsin 1.5 mg/day, Placebo, Placebo and Plitidepsin 1.5mg/day - Post COVID-19 Condition, Long COVID Syndrome | Phase 2 | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 90 | 2025-02-07 | 2026-10-08 |
| A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults CVXGA (CVXGA50), COMIRNATY® - COVID-19 | Phase 2 | Completed | CyanVac LLC | 432 | 2024-12-05 | 2026-10-13 |
| A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People Investigational Influenza Vaccine, COVID-19 Vaccine, Investigational Influenza/COVID-19 Vaccine - Influenza,Human, COVID-19 | Phase 1 / Phase 2 | Completed | BioNTech SE | 1353 | 2024-11-11 | 2026-08-19 |
| Individualizing Corticosteroid Use in Pneumonia Dexamethasone - Pneumonia | Phase 2 | Completed | Mayo Clinic | 24 | 2024-11-06 | 2026-08-05 |
| RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia) Modafinil, Modafinil Placebo, Solriamfetol - Long COVID, Long COVID-19 | Phase 2 | Completed | Duke University | 361 | 2024-08-12 | 2026-06-03 |
| RECOVER-SLEEP: Platform Protocol Modafinil, Modafinil Placebo, Solriamfetol - Long COVID, Long COVID-19 | Phase 2 | Completed | Duke University | 830 | 2024-07-31 | 2026-01-22 |
| RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD) Melatonin, Melantonin Placebo, Tailored lighting (TL) Active - Long COVID, Long COVID-19 | Phase 2 | Completed | Duke University | 469 | 2024-07-31 | 2026-07-08 |
| To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA COVIGENIX VAX- 002 - COVID-19 | Phase 1 / Phase 2 | Completed | Entos Pharmaceuticals Inc. | 46 | 2024-07-22 | 2025-12-16 |
| Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy FA Pneumonia Panel - Pneumonia, Critically Ill | Phase 2 | Completed | Chinese University of Hong Kong | 40 | 2024-06-26 | 2026-03-06 |
| Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 IMNN-101 - SARS CoV 2 Infection | Phase 1 / Phase 2 | Completed | Imunon | 24 | 2024-06-04 | 2025-07-23 |
| RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG) IVIG (intravenous immunoglobulin), IVIG Placebo, Coordinated Care - Long COVID, Long Coronavirus Disease 2019 (Covid19) | Phase 2 | Completed | Kanecia Obie Zimmerman | 200 | 2024-05-08 | 2026-07-31 |
Showing 20 of 771. Sign in to see all of them.
COVID-19 (638) · Coronavirus Infections (123) · Post-Acute COVID-19 Syndrome (45) · Severe Acute Respiratory Syndrome (39) · Respiratory Distress Syndrome (36) · Pneumonia, Ventilator-Associated (22) · Virus Diseases (22) · Infections (15) · Community-Acquired Pneumonia (14) · Respiratory Insufficiency (14) · Pneumonia, Bacterial (13) · Pneumonia, Viral (11) · Sepsis (11) · Acute Lung Injury (10)
Respiratory Tract Diseases (768) · Respiratory Tract Infections (762) · Infections (756) · Lung Diseases (754) · RNA Virus Infections (670) · Nidovirales Infections (666) · Coronaviridae Infections (665) · Pneumonia, Viral (657) · Virus Diseases (654) · Coronavirus Infections (545) · Pathological Conditions, Signs and Symptoms (134) · Pathologic Processes (116) · Disease Attributes (83) · Chronic Disease (50)
Standard of Care (37) · Sodium Chloride (23) · Saline Solution (22) · BNT162 Vaccine (18) · 2019-nCoV Vaccine mRNA-1273 (13) · Hydroxychloroquine (13) · Ivermectin (12) · Ritonavir (11) · COVID-19 Serotherapy (9) · ChAdOx1 nCoV-19 (9) · Colchicine (8) · camostat (7) · favipiravir (7) · COVID-19 Vaccines (6) · CVnCoV COVID-19 vaccine (6)
National Institute of Allergy and Infectious Diseases (NIAID) (15) · BioNTech SE (13) · Novavax (8) · Pfizer (8) · Washington University School of Medicine (8) · AstraZeneca (7) · Hipra Scientific, S.L.U (7) · ModernaTX, Inc. (7) · Stanford University (7) · GlaxoSmithKline (6) · Assistance Publique - Hôpitaux de Paris (5) · Duke University (5) · Kanecia Obie Zimmerman (5) · NYU Langone Health (5) · AnGes, Inc. (4)
United States (302) · Spain (69) · Brazil (57) · United Kingdom (43) · France (40) · Russia (39) · China (38) · Canada (33) · South Africa (32) · Germany (29) · Italy (29) · Mexico (29) · Argentina (27) · Belgium (25) · South Korea (22)
Mikhail Samsonov (4) · Christina Barkauskas, MD (3) · Cyndya Shibao, MD (3) · Pam Taub, MD (3) · Peter Novak, MD (3)
PMID 34473343, PMID 35713300, PMID 34013969, PMID 36734509, PMID 37162745, PMID 34658014, PMID 32251768, PMID 33502773, PMID 33754144, PMID 35244208, PMID 40592258, PMID 41720282, PMID 23208422, PMID 32020029, PMID 32150618, PMID 32205204, PMID 32658300, PMID 32788708, PMID 32896291, PMID 33240091, PMID 33306989, PMID 33617777, PMID 33624010, PMID 34374951, PMID 34480858, PMID 34890537, PMID 35660738, PMID 36435633, PMID 36996150, PMID 37428653, PMID 38400102, PMID 38529685, PMID 39066372, PMID 39197299, PMID 40461100, PMID 11176912, PMID 14592603, PMID 15141377, PMID 15308692, PMID 15320751, PMID 15774846, PMID 15882530, PMID 1593279, PMID 15992957, PMID 16103202, PMID 16134130, PMID 17087696, PMID 17391816, PMID 18446504, PMID 18470901
2023 (3), 2019 (2), P30CA033572 (2), R01NR007652 (2), 1ZIDES102465 (1), 2008 (1), 2014 (1), 2015 (1), 2017 (1), 3UH3DK114920-04S2 (1), 5UM1AI148684-02 (1), 5UM1AI148684-03 (1), I21RX004409 (1), R01AI152078 (1), R01DE014685 (1)